TY - JOUR A1 - Adam, Elisabeth A1 - Haas, Victoria A1 - Lindau, Simone A1 - Zacharowski, Kai A1 - Scheller, Bertram T1 - Cholinesterase alterations in delirium after cardiosurgery: a German monocentric prospective study T2 - BMJ open N2 - Objectives: Postoperative delirium (POD) is a common complication after elective cardiac surgery. Recent evidence indicates that a disruption in the normal activity of the cholinergic system may be associated with delirium. Design: Prospective observational study. Setting: Single-centre at a European academic hospital. Primary: and secondary outcome measures In our study the enzyme activities of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) were determined preoperatively as well as on the first and second postoperative day. The confusion assessment method for the intensive care unit was used to screen patients for the presence of POD. Results: A total of 114 patients were included in the study. POD was associated with a decrease in BChE activity on postoperative day 1 (p=0.03). In addition, patients who developed POD, had significantly lower preoperative AChE activity than patients without POD (p<0.01). Multivariate analysis identified a preoperatively decreased AChE activity (OR 3.1; 95% CI 1.14 to 8.46), anticholinergic treatment (OR 5.09; 95% CI 1.51 to 17.23), elevated European System for Cardiac Operative Risk Evaluation (OR 3.68; 95% CI 1.04 to 12.99) and age (OR 3.02; 95% CI 1.06 to 8.62) to be independently associated with the development of POD. Conclusions: We conclude that a reduction in the acetylcholine hydrolysing enzyme activity in patients undergoing cardiac surgery may correlate with the development of POD. KW - acetylcholinesterase KW - butyrylcholinesterase KW - cardiac surgery KW - cholinesterase KW - postoperative delirium Y1 - 2020 UR - http://publikationen.ub.uni-frankfurt.de/frontdoor/index/index/docId/52993 UR - https://nbn-resolving.org/urn:nbn:de:hebis:30:3-529938 SN - 2044-6055 N1 - This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. VL - 10 IS - 1, e031212 SP - 1 EP - 10 PB - BMJ Publishing Group CY - London ER -